The C Terminus of the L-Type Voltage-Gated Calcium Channel CaV1.2 Encodes a Transcription Factor  by Gomez-Ospina, Natalia et al.
The C Terminus of the L-Type
Voltage-Gated Calcium Channel
CaV1.2 Encodes a Transcription Factor
Natalia Gomez-Ospina,1 Fuminori Tsuruta,1,3 Odmara Barreto-Chang,1,3 Linda Hu,2 and Ricardo Dolmetsch1,*
1Department of Neurobiology, Stanford University School of Medicine, 299 Campus Drive, Stanford, CA 94305, USA
2Division of Neurosciences, Children’s Hospital and Department of Neurobiology, Harvard Medical School, Boston,
MA 02115, USA
3These authors contributed equally to this work.
*Contact: ricardo.dolmetsch@stanford.edu
DOI 10.1016/j.cell.2006.10.017SUMMARY
Voltage-gated calcium channels play a central
role in regulating the electrical and biochemical
properties of neurons and muscle cells. One of
the ways in which calcium channels regulate
long-lasting neuronal properties is by activating
signaling pathways that control gene expres-
sion, but the mechanisms that link calcium
channels to the nucleus are not well under-
stood. We report that a C-terminal fragment of
CaV1.2, an L-type voltage-gated calcium chan-
nel (LTC), translocates to the nucleus and regu-
lates transcription. We show that this calcium
channel associated transcription regulator
(CCAT) binds to a nuclear protein, associates
with an endogenous promoter, and regulates
the expression of a wide variety of endogenous
genes important for neuronal signaling and
excitability. The nuclear localization of CCAT
is regulated both developmentally and by
changes in intracellular calcium. These findings
provide evidence that voltage-gated calcium
channels can directly activate transcription
and suggest a mechanism linking voltage-
gated channels to the function and differentia-
tion of excitable cells.
INTRODUCTION
Changes in intracellular calcium regulate many cellular
events, including synaptic transmission, cell division, sur-
vival, and differentiation. Voltage-gated calcium channels
are an important route of calcium entry and are essential
for converting electrical activity into biochemical events
in excitable cells (Catterall et al., 2005). Among the ten
different types of voltage gated calcium channels, L-type
channels (LTC), encoded by the CaV1.2 and CaV1.3 pore-forming subunits, are particularly effective at inducing
changes in gene expression that underlie plasticity and
adaptive neuronal responses (Bading et al., 1993). Cal-
cium influx through LTCs activates transcription factors
such as CREB, MEF, and NFAT (Graef et al., 1999; Mao
et al., 1999; Sheng et al., 1990) that lead to the expression
of genes such as c-fos and BDNF (Morgan and Curran,
1986; Murphy et al., 1991; Zafra et al., 1990). Two mech-
anisms link LTCs, particularly CaV1.2, to the activation of
transcription factors such as CREB. Calcium entering
through the channels can diffuse to the nucleus and
activate nuclear calcium-dependent enzymes, such as
CaMKIV, that regulate the activity of transcription factors
and coregulators (Hardingham et al., 2001). In addition,
calcium entering cells through LTCs can activate calcium-
dependent signaling proteins around the mouth of the
channel, which propagate the signal to the nucleus (Dei-
sseroth et al., 1998; Dolmetsch et al., 2001).
In this study we have identified a new mechanism by
which calcium channels control gene expression. We re-
port that neurons produce a C-terminal fragment of
CaV1.2 that can regulate transcription and that we call cal-
cium channel associated transcriptional regulator or
CCAT. CCAT is located in the nucleus of many neurons
in the developing and adult brain, and its production and
nuclear localization are regulated developmentally. In ad-
dition, calcium influx through LTCs and NMDA receptors
causes CCAT export from the nucleus. In the nucleus,
CCAT interacts with the transcriptional regulator p54(nrb)/
NonO and can activate transcription of both reporter and
endogenous genes. Using microarrays and real-time PCR,
we show that CCAT affects the transcription of many neu-
ronal genes, including a gap junction, an NMDA-receptor
subunit, and the sodium-calcium exchanger. CCAT binds
to the enhancer of theConnexin 31.1 gene (Cx31.1) and di-
rectly regulates both the expression of a Cx31.1 reporter
gene and the expression of the endogenous gene. Finally,
we show that CCAT expression can cause an increase
in neurite extension in primary neurons. This is the first
example of a calcium channel having a dual function as
an ion pore and a transcription factor.Cell 127, 591–606, November 3, 2006 ª2006 Elsevier Inc. 591
RESULTS
CCAT Is Found in the Nucleus of Neurons in the Brain
Experiments in neurons and cardiac myocytes have sug-
gested that the C terminus of CaV1.2 is proteolytically
cleaved, yielding a truncated channel and a cytoplasmic
C-terminal fragment (De Jongh et al., 1994; Gerhardstein
et al., 2000). To investigate the function of the C-terminal
fragment, we developed an antibody to a 14-amino acid
peptide in the C terminus of CaV1.2 (aa 2106–2120) and
used it to probe HEK 293T cells expressing CaV1.2. The
C-terminal antibody (anti-CCAT) recognizes both the
intact channel and a short cleavage product that cor-
responds to the C-terminal fragment. In contrast, an
antibody recognizing an epitope in the II-III cytoplasmic
loop of CaV1.2 (anti-II-III loop) detects full-length and C-
terminally truncated channels only (Figure 1A).
To determine where CCAT is localized in cells in the
brain, we purified nuclear, cytoplasmic, and membrane
fractions of postnatal day 7 (P7) rat brain cortex and used
western blotting to probe them with the anti-CCAT anti-
body (Figure 1B). Surprisingly, we found that the nuclear
extracts contained high levels of CCAT, suggesting that the
C terminus of CaV1.2 is localized in the nucleus of cells in
the brain. In contrast, the N-terminal portion of the channel
was localized in the membrane and cytoplasmic fractions,
as expected for an ion channel. To provide further evi-
dence that CCAT is indeed nuclear in neurons or glial cells,
we examined its localization by immunostaining primary
cortical cultures. The anti-CCAT antibody stained the cell
bodyand dendritesof neurons weakly (Figure1D), suggest-
ing that the anti-CCAT antibody recognizes some intact
CaV1.2 channels. Importantly, however, CCAT staining was
observed in the nucleus of many neurons and was particu-
larly pronounced in 10% of the cells (Figure 1C). In contrast,
the II-III loop antibody stained the cell bodies and dendrites
of neurons but was excluded from the nucleus, suggesting
that the full-length channel is not nuclear (Figure 1E).
To investigate which types of neurons have nuclear
CCAT, we costained neurons with anti-CCAT and with
antibodies that stain precursor cells (nestin), glial cells
(GFAP), excitatory neurons (VGLUT), or inhibitory neurons
(GAD65) in the cortex. We found that cells that have strong
nuclear CCAT also expressed glutamic acid decarboxy-
lase (GAD65), suggesting that CCAT is strongly nuclear
in inhibitory neurons that produce GABA (Figure 1F). To
determine if CCAT is also in the nucleus of neurons
in vivo, we used the anti-CCAT antibody to stain P30 rat
brain sections. A subset of cells in the thalamus (data
not shown), inferior colliculus (Figure 1G), inferior olivary
nucleus (Figure 1H), and in the olfactory bulb (Figure 1I)
displayed prominent nuclear CCAT staining. In the cortex
and the hippocampus, CCAT was nuclear in a small num-
ber of neurons, consistent with its localization in a subset
of GAD65-positive neurons in cortical cultures (data not
shown). Taken together, these experiments indicate that
CCAT is localized in the nucleus of inhibitory neurons, in
culture and in restricted regions of the brain in vivo.592 Cell 127, 591–606, November 3, 2006 ª2006 Elsevier Inc.To provide further evidence that CCAT can translocate
to the nucleus, we fused yellow fluorescent protein (YFP)
to the C terminus of full-length CaV1.2 (CaV1.2-YFP). We
observed cytoplasmic and nuclear fluorescence when
CaV1.2-YFP was expressed in neurons (Figure 2A), car-
diac myocytes (data not shown), or Neuro2A glioblastoma
cells (Figure S2). In contrast, in neurons expressing CaV1.2
tagged at its N terminus with YFP, the channel was local-
ized in the membrane and in the endoplasmic reticulum
(Figure 2B). We did not observe nuclear fluorescence in
HEK 293T cells expressing CaV1.2-YFP, consistent with
previous reports that in HEK 293T cells the C terminus of
CaV1.2 remains associated with the plasma membrane
following cleavage (Gao et al., 2001; Gerhardstein et al.,
2000; Hulme et al., 2005). However, a fusion of YFP and
the last 503 amino acids of CaV1.2 was nuclear and
formed distinct nuclear punctae in neurons, myocytes,
and HEK 293T cells (c503, Figures 2C and 2E). Interest-
ingly, this punctate pattern did not seem to be the result
of overexpression, as it was also observed in some neu-
rons by confocal imaging of endogenous CCAT staining
(Figure 2D) and it was enhanced by incubation in low cal-
cium media (Figure 3B). These experiments provide fur-
ther evidence that CCAT is indeed nuclear and suggest
that formation of punctae by endogenous CCAT is modu-
lated by signaling events in the cell.
Nuclear CCAT does not contain a canonical nuclear lo-
calization sequence, suggesting that it enters the nucleus
via an alternative pathway, perhaps as has been de-
scribed for Stat1 protein, where nuclear import is medi-
ated by direct interaction with nucleoporins (Marg et al.,
2004). To identify the regions of CCAT that are necessary
for its nuclear localization, we made truncations of the
503-YFP protein and introduced them in HEK 293T cells.
Deletion of the carboxyl end of CCAT and of amino acids
1642–1814 of CaV1.2 (c330) had little effect on the pro-
tein’s localization. In contrast, deletion of amino acids
1814–1864 (c280) decreased nuclear retention and abol-
ished punctae formation (Figures 2E and 2F). Comparison
of the CaV1.2 sequence from other vertebrates indicates
that this nuclear retention domain is conserved evolution-
arily (Figure S1A), suggesting that it plays an important
role in the function of CaV1.2 and CCAT proteins.
Endogenous CCAT is predicted to be a 75 kDa protein;
therefore, nuclear translocation of CCAT is likely to involve
an active process rather than passive diffusion across nu-
clear pores. To estimate the rate of CCAT import into the
nucleus, we used fluorescence recovery after photo-
bleaching (FRAP) and time-lapse microscopy of Neuro2A
cells expressing CaV1.2-YFP. After photobleaching of nu-
clear CCAT, nuclear fluorescence recovered over the
course of 300 s with a single exponential time course
(t = 48 ±16 s; n = 11), while cytoplasmic fluorescence de-
clined over the same time period (Figures 2G–2H). In con-
trol cells expressing YFP alone, we observed an almost
instantaneous recovery of nuclear fluorescence after
photobleaching, concomitant with a decrease in cytoplas-
mic fluorescence, consistent with the observation that
YFP diffuses rapidly through nuclear pores. The slow rate
of recovery of CCAT-YFP nuclear fluorescence suggests
that this protein is actively imported into the nucleus at
a rate similar to that of NFAT, another transcription factor
that translocates to the nucleus (Shibasaki et al., 1996).
Measurements of CCAT export by bleaching cytoplasmic
fluorescence indicate that CCAT returns to the cytoplasm
with a time course of approximately 400 s (t = 62 ±21 s;
n = 5) (data not shown). These results are consistent
with the idea that CCAT is constitutively transported into
the nucleus and that CCAT shuttles between the cyto-
plasm and the nucleus of unstimulated cells.
The Concentration of Nuclear CCAT Is Regulated
by Intracellular Calcium
To determine whether the nuclear localization of CCAT is
regulated by changes in intracellular calcium, we as-
sessed the distribution of CCAT by immunocytochemistry
in cortical neurons following treatment with agents that
affect intracellular calcium levels. Decreasing free extra-
cellular calcium using 2.5 mM EGTA caused a robust in-
crease in nuclear CCAT fluorescence (Figures 3A and
3C) and caused CCAT to aggregate into punctae in the nu-
cleus of many neurons (Figure 3B). Conversely, treatment
with 65 mM KCl, which mimics tonic electrical activity
by increasing the activity of VGCCs, and treatment with
100 mM glutamate caused a significant decrease in the nu-
clear fluorescence (Figures 3A and 3C). The decrease in
nuclear CCAT could be reliably detected after 5 min and
reached a maximum after 30 min of stimulation with either
depolarization or glutamate, although depolarization had
a more pronounced effect at earlier time points (Figure 3D).
The nuclear fluorescence of Neuro2A cells expressing the
CaV1.2-YFP also declined with tonic depolarization, pro-
viding further evidence that electrical activity leads to
a net decrease of CCAT from the nucleus (Figure S2A–
S2B). The decrease in nuclear CCAT triggered by depolar-
ization was blocked by removing extracellular calcium or
by treating cells with the CaV1.2 blocker nimodipine. Ap-
plication of NMDA-receptor blocker MK-801 partially
blocked the activity-induced decrease in nuclear CCAT,
but treatment with the AMPA-receptor inhibitor NBQX
had no effect (Figure 3E), suggesting that NMDA but not
AMPA receptors can also influence the export of CCAT
from the nucleus of cortical neurons.
The decrease in nuclear CCAT observed in response to
high intracellular calcium could be due to a net export from
the nucleus or to selective degradation of CCAT in the nu-
cleus. To determine if CCAT is degraded following a rise in
intracellular calcium, we measured total CCAT immunore-
activity before and after depolarization. We found that de-
polarization had no effect on the total CCAT staining in
neurons or on the levels of CCAT-YFP expressed in Neu-
ro2A cells (Figure 3F). Furthermore, addition of the proteo-
some inhibitor lactacystin failed to block the depolariza-
tion-induced decrease in nuclear CCAT (Figure 3G). The
lack of a decrease in total CCAT levels in depolarized neu-
rons and Neuro2A cells and the lack of effect of lactacystinon CCAT nuclear localization argue that the decrease
in CCAT following depolarization is not due to protein
degradation.
Nuclear CCAT Is Regulated Developmentally
The levels of nuclear CCAT vary considerably among neu-
rons in the developing brain (Figures 1G–1I). Since neu-
rons in the central nervous system differentiate at different
rates, we considered whether the levels of CCAT in the nu-
cleus could be regulated developmentally. To investigate
this possibility, we assessed the levels of nuclear and total
CCAT found in brains taken from embryonic day 18 (E18),
postnatal day 1 (P1), 3-week-old (P21), and adult rats. The
levels of CCAT immunoreactivity in the nuclear fractions
increased substantially with age (Figure 3H, middle panel),
whereas the amount of CCAT-containing channel at the
membrane appeared to decrease (Figure 3H, upper
panel). This is consistent with increasing cleavage of
CaV1.2 during development. The total levels of CaV1.2,
as determined by immunoreactivity of the CaV1.2 inter-
nal-loop antibody, were also regulated developmentally.
CaV1.2 levels were low at E18 and increased through P8
before declining in P21 and adult brains (Figure 3I, upper
panel). Interestingly, early in development a long and
a short form of CaV1.2 could be detected, whereas only
the short form of the channel and a new, 150 kDa band
were observed in both P21 and adult brains, suggesting
that there is increasing cleavage and possibly different
cleavage events in older brains. Together, these results in-
dicate that the levels of CCAT in the nucleus, the cleavage
of CaV1.2, and the levels of CaV1.2 are regulated indepen-
dently to yield a complex pattern of channel- and tran-
scription-factor expression.
CCAT Binds to a Nuclear Protein
To get an indication of CCAT’s function, we looked for pro-
teins that interact with CCAT in the nucleus. We expressed
CCAT or a mutant form lacking the nuclear localization do-
main in Neuro2A cells, immunoprecipitated them via epi-
tope tags, and identified interacting proteins by mass
spectrometry. One of the proteins that coimmunoprecipi-
tated with full length CCAT was p54(nrb)/NonO, a nuclear
protein that plays a role in regulating transcription down-
stream of the neuronal Wiscott Aldrich Protein (Wu et al.,
2006), the retinoic acid receptor, and the thyroid hormone
receptor (Mathur et al., 2001). We verified the interaction
of p54(nrb)/NonO with CCAT by coimmunoprecipitation
followed by Western blotting against endogenous
p54(nrb)/NonO (Figure 4A). These results indicate that
CCAT is associated with a nuclear protein that partici-
pates in transcriptional regulation and regulates mRNA
splicing, and suggest a role for the C terminus of CaV1.2
in the nucleus.
CCAT Activates Transcription
Based on its nuclear localization and its binding to
p54(nrb)/NonO, we hypothesized that CCAT might reg-
ulate transcription. To investigate whether CCAT canCell 127, 591–606, November 3, 2006 ª2006 Elsevier Inc. 593
Figure 1. The C Terminus of Cav1.2 Is Found in the Nucleus of Neurons
(A) Western blot of HEK 293T cells expressing Cav1.2 probed with anti-II-III loop antibody (left gel) or anti-CCAT (right gel). The first lane of each gel
contains lysate from untransfected cells (Unt), and the second contains lysate from cells expressing CaV1.2.
(B) Western blots of membrane (Mem), nuclear (Nuc), and cytoplasmic (Cyt) extracts from the cortex of P7 rats analyzed with the anti-CCAT (upper
gel), anti-CREB (second gel), anti-Cav1.2 II-III loop (third gel), and anti-GAPDH (bottom gel) antibodies. The first two lanes contain extracts from HEK
293T cells expressing Cav1.2. CREB, and CCAT immunoreactivity are detected only in the nuclear fraction, Cav1.2 probed with anti-II-III loop antibody
and GAPDH are found in the membrane and cytoplasmic fractions confirming the efficacy of the fractionation.
(C) Immunocytochemistry of cortical neurons grown 6 days in vitro. Anti-CCAT staining is shown in green and nuclei is shown in blue.
(D) High-power image shows strong anti-CCAT staining (green) of nuclei (blue) and lighter staining of dendrites.
(E) Staining with anti-CaV1.2 II-III loop antibody (green) reveals strong membrane and ER staining but little nuclear staining (blue).
(F) Costaining with anti-CCAT antibody (green) and anti-GAD65 antibody (red) reveals that CCAT is strongly nuclear in a subpopulation of GAD65-
positive neurons.594 Cell 127, 591–606, November 3, 2006 ª2006 Elsevier Inc.
activate transcription when recruited to a promoter by
a heterologous DNA binding domain, we made a C-termi-
nal fusion of the intact channel and the Gal4-DNA binding
domain from yeast (CaV1.2-Gal4, Figure 4B). The Gal4-
DNA binding domain recognizes the UAS-DNA sequence
but requires a transcriptional activation domain to activate
transcription. We introduced CaV1.2-Gal4 into Neuro2A
cells along with a UAS-luciferase-reporter gene and mea-
sured luciferase expression. We found that CaV1.2-Gal4
activated transcription approximately 80 times better
than Gal4 alone or than the channel lacking the Gal4-
DNA binding domain (Figure 4C). These results suggest
that the C terminus of CaV1.2 is produced as a soluble pro-
tein in cells, that it translocates to the nucleus, and that it
activates transcription when recruited to a heterologous
gene.
To identify the domains of CaV1.2 that are required for
transcriptional activation, we made a family of proteins
containing fragments of the C terminus of CaV1.2 fused
to Gal4 and tested them in primary neurons for their ability
to activate the expression of a UAS-luciferase-reporter
gene. A fragment containing 503 amino acids of the
CaV1.2 C terminus fused to Gal4-activated transcription
almost as well as a CREB-Gal4 fusion protein and about
130 times better than the Gal4-DNA binding domain alone
(Figure 4D). Deleting 170 amino acids from the N terminus
of this C-terminal CaV1.2 fragment (c330-Gal4) reduced
but did not completely abolish the ability of the C terminus
to activate transcription. In contrast, deletion of a second
domain consisting of the most C-terminal 133 amino acids
(c503D133-Gal4) completely eliminated the ability of
CCAT to activate transcription (Figure 4D). Deletion of
these final 133 amino acids in the full-length CaV1.2-
Gal4 also produced a channel unable to activate tran-
scription (Figure 4C, bar 4), suggesting that this domain
is required for transcriptional regulation by the intact chan-
nel. These experiments suggest that CCAT has two do-
mains that are necessary to activate transcription: (1) an
N-terminal domain that modulates transcriptional activa-
tion and (2) a C-terminal domain that is essential for tran-
scription (red and blue boxes; Figure 4B). Significantly,
both transactivation domains are highly conserved in ver-
tebrates (Figure S1B and S1D) and the N-terminal transac-
tivation domain has 42% similarity and 27% identity to
a conserved transactivation domain of the transcription
factor GATA4, suggesting that it has a bona fide role in
transcriptional regulation (Figure S1C).
Because recruiting proteins to DNA via Gal4-DNA bind-
ing domains can produce ectopic transcriptional reg-
ulators, we also fused various other calcium channel
C-terminal domains to Gal4 and expressed these with
the UAS-reporter gene. We found that the C termini of
CaV1.3 and CaV2.1 when fused to Gal4 had no effect ontranscription, suggesting that CaV1.2’s C-terminal domain
is specific in its ability to activate transcription in neurons
(Figure 4E).
In earlier experiments, we observed that the amount of
CCAT in the nucleus decreased in response to tonic elec-
trical activity. To determine whether this activity-induced
decrease in nuclear CCAT has functional relevance, we
depolarized cells expressing CaV1.2-Gal4 and measured
activation of the UAS-luciferase reporter (Figure 4F). Pro-
longed depolarization led to a 30% decline in transcription
from the reporter gene, and this effect was blocked by re-
moving extracellular calcium. These results provide evi-
dence that the nuclear localization of CCAT is important
for its activation of transcription and are consistent with
the observation that nuclear-CCAT concentration is regu-
lated by electrical activity.
CCAT Regulates Transcription of Endogenous
Genes
To determine whether CCAT regulates transcription of en-
dogenous genes, we used oligonucleotide microarrays to
identify mRNAs that are transcriptionally regulated by
CCAT overexpression. We built two plasmids that encode
either full-length CCAT or a CCATDTA that lacks the N-
terminal transcriptional-activation domain. Both plasmids
also contain a GFP gene driven by a separate promoter
that was used to identify transfected cells. We introduced
these plasmids into Neuro2A cells and used fluorescence-
activated cell sorting (FACS) to select transfected cells.
We then compared the mRNA-expression profile of cells
expressing full-length CCAT to cells expressing either
CCATDTA or GFP alone, using Agilent mouse whole-
genome arrays. In three independent experiments, we
found 23 mRNAs that were upregulated more than
2-fold (p < 0.005) in cells expressing CCAT relative to
cells expressing CCATDTA and 22 genes that were down-
regulated more than 2-fold by CCAT relative to CCATDTA
(Table S1). Because we subsequently discovered the
CCATDTA still activates transcription albeit at a much
lower level than full-length CCAT (see Figure 4D), we also
compared mRNA-expression profiles of cells expressing
CCAT and GFP to cells expressing GFP alone. In three
additional experiments, we found 66 mRNAs upregulated
more than 1.8-fold (p < 0.005) in cells expressing CCAT
relative to those expressing GFP (Figure S1 and Table
S2). The genes that were upregulated by CCAT include
the genes for the gap junction protein Cx31.1, the axon
guidance factor Netrin4, the regulator of G-protein signal-
ing RGS5, the tight junction protein claudin19 and a broad
array of other genes (Figure 5A). Approximately 206 genes
were repressed more than 0.55-fold (p < 0.005) by
CCAT, including the sodium-calcium exchanger, the cat-
ion channel TRPV4, the potassium channel Kcnn3, and(G and H) Immunohistochemistry of P30 rat-brain sagittal sections reveals strong nuclear staining with the anti-CCAT antibody (green) in the inferior
colliculus (G:IC) and inferior olivary nucleus (H:IO). The cerebellum is labeled C and the brain stem is labeled BS.
(I) High-power images of anti-CCAT (green), anti-GAD65 (red), and nuclear (blue) staining of rat olfactory lobe neurons shows that only a subpopulation
of neurons have nuclear CCAT and that many of the cells are positive for GAD65.Cell 127, 591–606, November 3, 2006 ª2006 Elsevier Inc. 595
Figure 2. Ectopically Expressed CCAT Localizes to the Nucleus of Neurons via a Nuclear Retention Domain
(A) Neurons expressing Cav1.2 tagged at the C terminus with YFP (Cav1.2-YFP) show pronounced nuclear and cytoplasmic fluorescence. Nuclei are
shown in red in all panels.
(B) Neurons expressing the Cav1.2 tagged at the N terminus with YFP (YFP-Cav1.2) show membrane and ER fluorescence but little nuclear
fluorescence.
(C) Full-length CCAT-YFP (c503-YFP) is nuclear when expressed in neurons, cardiac myocytes, and HEK 293T cells and forms prominent punctae.
(D) Epifluorescence (left panel) and confocal (right panel) image of neurons stained with anti-CCAT antibody showing endogenous nuclear punctae.
(E) Schematic representation of YFP-tagged CCAT-deletion mutants (top). Top panel and second panels show nuclear punctae in HEK 293T cells
expressing CCAT containing a deletion of 133 aa from the carboxyl terminus (c503–133) and a truncated CCAT lacking aa 1642–1814 of Cav1.2
(c330) respectively. The third panel shows cells expressing a truncated CCAT lacking aa 1814–1864 (c280). The domain important for nuclear local-
ization is highlighted in red in the schematic.
(F) Mean nuclear to cytoplasmic fluorescence ratios for all the CCAT deletions constructs schematized in part (E) (means ± SEM; n > 75). ** p < 0.001
versus c503.
(G) Time-lapse images showing fluorescence recovery after photobleaching (FRAP) of Cav1.2-YFP in the nucleus of Neuro2A cells. The area outlined
in the red circle was bleached for 300 ms with a high-intensity pulsed 488 nM laser beam. Images were collected every 300 ms.596 Cell 127, 591–606, November 3, 2006 ª2006 Elsevier Inc.
the transcription factor GATA6 (Figures 5A and S3 and Ta-
ble S3; raw data available at http://ncbi.nlm.nih.gov/geo;
series #: GSE4180). Combining the results from all six
of our microarray experiments (CCAT versus CCATDTA
and CCAT versus GFP) revealed that 16 mRNAs were
significantly upregulated (Table S4) and 31 genes were
significantly downregulated by CCAT. These results sug-
gest that CCAT can both increase and decrease the ex-
pression of a wide set of genes that regulate neuronal
differentiation, connectivity, and function.
To verify the results of the microarray experiments, we
measured changes in mRNA expression due to CCAT
expression using RT-PCR (Figure 5B). CCAT changed
the expression of all seven mRNAs tested, in accor-
dance with the results from the array experiments. As
normalizing controls we used b-actin and GAPDH, which
showed no detectable change in response to overex-
pression of CCAT. These data provide independent evi-
dence that CCAT regulates expression of endogenous
genes, some of which are important for the function of
excitable cells.
CCAT Binds and Regulates the Promoter of Cx31.1
The microarray and RT-PCR experiments suggested that
Cx31.1 was strongly regulated by CCAT in cells. To study
the regulation of Cx31.1 by CCAT in more detail, we con-
structed a reporter gene consisting of the 2 Kb promoter/
enhancer region of Cx31.1 in front of the firefly-luciferase-
coding sequence. We introduced this Cx31.1-luciferase-
reporter gene into neurons along with either the full-length
CCAT or CCATDTA, a version of CCAT lacking the C-
terminal transcriptional activation domain. Full-length
CCAT increased the expression of the Cx31.1 reporter
by 3.4 ± 0.4-fold (n = 12) relative to a control vector or to
CCATDTA (Figure 5C) providing additional evidence that
CCAT regulates the expression of Cx31.1.
CCAT could affect the transcription of Cx31.1 either by
regulating the transcriptional machinery in the nucleus di-
rectly or by modifying signaling proteins in the cytoplasm
of cells that lead to changes in transcription. To determine
if CCAT acts in the nucleus, we fused CCAT to the ligand
binding domain of a modified estrogen receptor (ER) that
binds 4-hydroxytamoxifen (4OHT) but not endogenous
estrogen (Littlewood et al., 1995). When expressed in
Neuro2A cells, ER-CCAT is largely excluded from the nu-
cleus but brief treatment with 4OHT causes ER-CCAT to
move into the nucleus (Figure 5D). Treatment of cells ex-
pressing ER-CCAT with 4OHT caused a 50-fold increase
in the transcription of Cx31.1 relative to untreated cells
(Figure 5E). 4OHT had no effect on cells expressing ER
alone and caused a much smaller effect in cells express-
ing ER-CCATDTA. These results provide compelling evi-
dence that CCAT regulates the transcription of Cx31.1
when it is in the nucleus of cells.To identify regions of the Cx31.1 promoter that are im-
portant for its regulation by CCAT, we made a series of de-
letions of the Cx31.1 promoter and placed them upstream
of the firefly-luciferase gene (Figure 5F). We introduced
this library of deletion mutants of the Cx31.1 promoter
into Neuro2A cells along with full-length CCAT and mea-
sured luciferase activity in these cells. CCAT regulation
of the Cx31.1 promoter was critically dependent on 148
base pairs at the 30 end of the Cx31.1 promoter. Deletion
of this domain eliminated the ability of CCAT to activate
transcription of the Cx31.1-reporter gene, and this domain
alone was sufficient to confer CCAT regulation on to a re-
porter gene (Figure 5F). Together, these data suggest that
CCAT regulates the expression of Cx31.1 in a sequence-
specific manner and that the CCAT-recognition element
lies in the final 148 base pairs of the Cx31.1-promoter
sequence.
In the nucleus, CCAT could affect transcription directly
by binding to a complex of proteins on the promoter of
genes, or indirectly by binding to other proteins in the tran-
scriptional-activation pathway. We used chromatin immu-
noprecipitation (ChIP) to determine whether CCAT binds
to the promoter of Cx31.1 directly. We introduced an epi-
tope-tagged CCAT into cells, crosslinked the protein to
the DNA, and immunoprecipitated CCAT from these cells
and used PCR to determine if any region in the promoter of
the Cx31.1 gene was coimmunoprecipitated by CCAT.
We found that CCAT reproducibly immunoprecipitate
two fragments of the endogenous Cx31.1 promoter but
not a 3 region of the gene (Figure 5G). These results sug-
gest that CCAT regulates transcription by binding, either
directly or through protein-protein interactions, to the pro-
moter of Cx31.1, providing further evidence that CCAT is
a transcriptional regulator.
Endogenous CaV1.2 and CCAT Regulate
Transcription of Cx31.1
We have provided evidence that exogenous expression
of CaV1.2 leads to the production of CCAT, which in turn
affects transcription. To determine whether endogenous
CaV1.2 regulates transcription by generating CCAT,
we asked whether reducing the levels of endogenous
CCAT in the nucleus by depolarization had an effect on ex-
pression of the Cx31.1-reporter gene or of the endoge-
nous Cx 31.1 gene. Depolarization of cortical neurons re-
duced activation of the Cx31.1-reporter gene by 2.12 ±
0.12-fold (Figure 6A) and caused a 2.4-fold decrease in
the expression of the Cx31.1-mRNA levels as measured
by RT-PCR (Figure 6B). The effects of depolarization on
Cx31.1-mRNA levels were also apparent in Neuro2As
and in cultured thalamic neurons, suggesting that CCAT
regulates the expression of Cx31.1 in multiple cell types
(Figure 6B). These results support the conclusion that(H) Time course of recovery of nuclear fluorescence (solid symbols) and time course of loss of cytoplasmic fluorescence (empty symbols) following
bleaching. Nuclear fluorescence recovered with a time course faster than 300 ms in cells expressing YFP alone. Shown is a representative example of
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Figure 3. The Nuclear Localization of CCAT Is Regulated by Intracellular Calcium and by Developmental Processes in the Brain
(A) Cortical neurons stained with anti-CCAT antibody (green) and Hoechst (red) treated with 5 mM K+ (1 hr), 65 mM K+ (1 hr), 100 mM glutamate
(30 min), or 2.5 mM EGTA (1 hr).
(B) Higher magnification image of neurons treated with 2.5 mM EGTA reveals strong and punctate anti-CCAT staining.
(C) Histograms of the ratio of nuclear to cytoplasmic anti-CCAT fluorescence in neurons treated with 65 mM K+, glutamate, or EGTA. Treatment with
100 mM glutamate (blue) and 65 mM K+ (green) reduce the amount of CCAT in the nucleus of neurons, while EGTA (red) increases the amount of CCAT
in the nucleus. Control cells in 5 mM K+ are shown in black (n = 375 per condition).598 Cell 127, 591–606, November 3, 2006 ª2006 Elsevier Inc.
Figure 4. The C Terminus of Cav1.2 Binds
to Nuclear Proteins and Activates
Transcription
(A) CCAT immunoprecipitates endogenous
p54(nrb)/NonO. Upper panel shows p54nrb/
NonO levels in the lysates. The middle panel
shows immunoprecipitated c503-Gal4 and
c280-Gal4 that lacks a nuclear localization do-
main. The lower panel shows endogenous
p54(nrb)/NonO coimmunoprecipitated by c503-
Gal4 but not by c280-Gal4.
(B) Schematic representation of the CaV1.2-
Gal4 fusion and CCAT deletion proteins. c503
CCAT is the full-length C terminus of CaV1.2
downstream of the IQ motif. c330 CCAT lacks
the N-terminal transcriptional activation do-
main (shown in red). c280 lacks the nuclear re-
tention domain of CCAT and c503D133 lacks
the C-terminal transactivation domain (shown
in blue).
(C) Reporter gene activity of Neuro2A cells ex-
pressing a UAS-luciferase-reporter plasmid
along with either the Gal4-DNA binding do-
main, full-length CaV1.2, full-length CaV1.2-
Gal4, or CaV1.2-Gal4 channel lacking 133
amino acids from the carboxyl terminus. Cells
were cotransfected with a Renilla driven by
the thymidine kinase promoter to control for
cell number and transfection efficiency. The re-
sults are given as the ratio of Firefly to Renilla-
luciferase activity. (means ± SD) ** p < 0.0001
versus Gal4.
(D) Luciferase activity of neurons transfected
with the UAS-luciferase-reporter gene and ei-
ther Gal4 alone, CREB-Gal4, or four different
CaV1.2 C-terminal fragments c503, c330, or
c280 and C503D133 fused to Gal4. The two do-
mains identified as important for transcriptional
activation are highlighted in B. (means ± SD;
** p < 0.005)
(E) Luciferase activity of neurons transfected with Gal4-DNA binding domain alone or Gal4 fused to the C terminus of CaV1.2, CaV1.3, or CaV2.1. (means±
SD) ** p < 0.0001 versus Gal4.
(F) Luciferase activity of Neuro2A cells expressing CaV1.2-Gal4 treated with 5 mM, 65 mM, and 65 mM K
+/2.5 mM EGTA. (means±SD; ** p < 0.005 versus
untreated).CCAT-dependent transcription of the Cx31.1 gene re-
quires nuclear localization of CCAT.
Because CCAT is derived from CaV1.2, we also asked
whether Cx31.1 expression depends on the expression
of endogenous CaV1.2. We designed several short hairpin
RNAs (shRNAs) and asked whether introducing these
shRNAs into neurons reduced the expression of Cx31.1.
Two shRNAs targeting the rat CaV1.2 (RCav1.2 sh6410and RCaV1.2 sh6500) reduced the expression of rat
CaV1.2 expressed in Neuro2A cells, whereas an shRNA
targeting the mouse CaV1.2 sequence had no effect on
the expression of the rat channel (Figure 6C, lanes 1–3).
The shRNAs targeting the rat CaV1.2 also reduced
CaV1.2-dependent signaling to CREB in rat-cortical neu-
rons, suggesting that these shRNAs reduce the expres-
sion of endogenous CaV1.2 and prevent activation of(D) Time course of the decrease in anti-CCAT nuclear fluorescence following stimulation with 65 mM K+ (green line; n = 200) or 100 mM glutamate (blue
line; n = 200).
(E) Mean nuclear to cytoplasmic fluorescence ratio of CCAT in neurons treated for 1 hr with 2.5 mM EGTA (bar 2), 65 mM K+ (bar 3), and 65 mM K+ in
the presence of 2.5 mM EGTA, 10 mM nimodipine, 10 mM MK-801 or 10 mM NBQX (bars 5–8; n = 200). (means ± SEM) * p < 0.001
(F) Mean anti-CCAT cell body fluorescence in neurons treated with 5mM or 65mM K+ (n=50).
(G) Mean nuclear to cytoplasmic fluorescence ratio of CCAT in neurons treated with 5mM and 65mM K+ in the presence of 5mM lactacystin (n=50).
(H) Western blot analysis of membrane (top) and nuclear fractions (middle) obtained from E18, P1, P21, and adult-brain cortex probed with the anti-
CCAT antibody. CREB was used as a loading control (lower gel).
(I) Western blot analysis of cortical membrane extracts obtained from E18, P1, P8, P21, and adult rats analyzed with anti-CaV1.2 II-III loop antibody
(top gel) and anti-b-actin (bottom) as a loading control. Adult lane exposed 4X relative to other lanes.Cell 127, 591–606, November 3, 2006 ª2006 Elsevier Inc. 599
Figure 5. CCAT Regulates Endogenous Genes
(A) A subset of mRNAs identified in microarray experiments that were upregulated (red bars) or downregulated (green bars) by overexpression of
CCAT relative to CCATDTA or GFP. For a full list of genes, see Tables S1–S4.
(B) RT-PCR analysis of mRNA levels from Neuro2A cells overexpressing CCAT confirming changes in gene expression for a subset of these genes
identified in A. Bars represent mean fold changes relative to CCATDTA or GFP and were normalized to b-actin and GAPDH levels. Data are means ±
SD of three independent experiments performed in triplicate.600 Cell 127, 591–606, November 3, 2006 ª2006 Elsevier Inc.
CREB-dependent transcription (Bading et al., 1993; Dol-
metsch et al., 2001; Murphy et al., 1991) (Figure S4A).
We next introduced the shRNAs targeting the rat CaV1.2
into cortical neurons and measured the activation of the
Cx31.1 reporter. Both rat shRNAs decreased the expres-
sion of Cx31.1 by approximately 6-fold, indicating that
CaV1.2 regulates the expression of Cx31.1 in neurons
(Figure 6D). CaV1.2 knockdown had no effect on Renilla-
luciferase expression from the control vector, suggesting
that the decrease in Cx31.1-reporter activity was not
due to decreased viability. To assess whether the effect
of the shRNAs targeting CaV1.2 on the transcription of
Cx31.1 was the result of the loss of calcium influx through
the channel, we tested whether L-type calcium channel
blockers affected Cx31.1 transcription. Twenty-four hr
treatment of neurons with 10 mM nimodipine had no effect
on the expression of Cx31.1 in the presence or absence of
CCAT, suggesting that Cx31.1 is not regulated by calcium
influx through CaV1.2 in unstimulated cells (Figure S4B).
To determine if the inhibitory effects of CaV1.2 shRNAs
on the Cx31.1 promoter are due to reduction of CCAT,
we constructed a version of CCAT that is insensitive to
the rat CaV1.2 shRNA (CCAT*, Figure 6E) and expressed
it in cells along with the shRNA targeting rat CaV1.2.
Expression of CCAT* rescued the effect of knocking
down the endogenous CaV1.2 on the expression of the
Cx31.1 gene (Figure 6F, n = 6). In contrast, CCATDTA
that lacked the transcriptional-activation domain did
not rescue the effects of the CaV1.2 shRNA on Cx 31.1
expression. This suggests that CCAT alone can restore
expression of Cx 31.1 in cells in which CaV1.2 has been
reduced by an shRNA and that this effect depends on
the transcriptional-activation domain of CCAT. We also
made a version of CaV1.2 that is insensitive to the rat
CaV1.2 shRNA (CaV1.2*) (Figure 6G) and asked whether
this channel can rescue Cx31.1 expression in cells lacking
endogenous CaV1.2 (Figure 6H). Expression of CaV1.2* in
neurons partially rescued the effect of the CaV1.2 shRNA
on Cx31.1 expression, while a form of CaV1.2* that lacks
the C-terminal transcriptional-activation domain did not
restore the effects of CaV1.2 knockdown on Cx31.1 ex-
pression. Together these results support the conclusion
that endogenous CaV1.2 modulates transcription of the
Cx31.1 gene and that this transcriptional regulation de-
pends on the production of CCAT from the C terminus of
CaV1.2.CCAT Expression Promotes Neurite Growth
Our microarray and RT-PCR experiments suggested that
CCAT regulates the transcription of a number of genes im-
portant in neuronal function and excitability. To explore
the cell biological functions of CCAT, we measured the ef-
fect of expressing CCAT on the morphology and survival
of cerebellar granule neurons. We selected these cells be-
cause they are a largely homogenous population of neu-
rons that have low basal levels of CCAT and that have
well-characterized survival and dendritic arborization pat-
terns. Expression of CCAT or CCATDTA did not signifi-
cantly affect granule cell survival, but it did cause a dra-
matic change in the length of neurites (Figures 7A and
7B). Full-length CCAT doubled the average length of neu-
rites to 10 mm (Figures 7C [bottom panel] and 7D) whereas
the CCATDTA decreased the average length of neurites to
approximately 2.7 um (Figures 7C [top panel] and 7D).
There was also a small but statistically significant effect
of CCAT on the number of neurites, suggesting that under
some circumstances CCAT could affect the growth and
formation of new dendrites (Figure 7E). Interestingly, ex-
pressing CCAT in other cell types such as Neuro2As
also caused a change in the morphology of the cells, caus-
ing an increase in the production of filopodial extensions
(data not shown). This data suggests that CCAT-depen-
dent transcription can lead to rearrangement of the cyto-
skeleton and may contribute to changes in the connectiv-
ity of neurons during development.
DISCUSSION
Neurons and myocytes generate characteristic patterns of
electrical activity and intracellular calcium that are essen-
tial for cell function. The reliability of the calcium signal re-
quires a delicate balance of proteins that import and
export calcium from the cytoplasm—proteins whose indi-
vidual expression is regulated independently in response
to cellular function. The expression of voltage-gated cal-
cium channels is closely coordinated with the expression
of other ion channels, pumps, and signaling proteins that
regulate membrane excitability and calcium homeostasis.
In this paper we describe a novel mechanism by which
cells coordinate the expression of voltage-gated calcium
channels with the expression of other molecules. LTCs
generate a transcription factor that integrates information
both about the number of calcium channels and the(C) Luciferase activity of neurons expressing a Cx31.1-luciferase-reporter gene along with empty vector, full-length CCAT, or CCAT lacking the C-
terminal transactivation domain (CCATDTA) (means ± SD; ** p < 0.0001).
(D) 4OHT-induced nuclear translocation of a CCAT-ER fusion. Immunocytochemistry of Neuro2A cells expressing myc-CCAT-ER (green) before (top
panels) and after (bottom panels) addition of 5 mM 4OHT for 1 hr. Nuclei are shown in blue.
(E) Transcription of a Cx31.1-luciferase-reporter gene in Neuro2A cells expressing a Cx31.1-luciferase reporter along with ER alone, CCAT-ER, or
CCATDTA-ER before and after nuclear translocation by addition of 5 mM 4OHT for 6 hr.
(F) Mean luciferase activity (mean ± SEM; n = 3) of Neuro2A cells expressing CCAT and deleted forms of the Cx31.1 promoter. The 125 bp 30 region of
the promoter that binds CCAT is shown in red.
(G) Representative ChIP assay showing that CCAT immunoprecipitates the endogenous Cx31.1 promoter. Agarose gel electrophoresis of PCR prod-
ucts amplified from either input DNA (I) or from DNA that was immunoprecipitated by GST-CCAT (IP) or by GST alone (C). The upper gel shows the
PCR products using primers that recognize two regions in the Cx31.1 promoter (50 promoter and 30 promoter). The lower gel shows PCR products
using primers that recognize the 30 region of the Cx31.1 gene several KB from the start site (n = 3).Cell 127, 591–606, November 3, 2006 ª2006 Elsevier Inc. 601
Figure 6. Endogenous CCAT Regulates
Transcription Driven by the Cx31.1
Promoter
(A) Depolarization of neurons with 65 mM KCl
decreases the activity of the Cx31.1 reporter
relative to unstimulated cells (5 mM KCl;
mean ± SD; n > 3; ** p < 0.0001).
(B) RT-PCR analysis of endogenous Cx31.1
mRNA in Neuro2A cells and cortical and tha-
lamic neurons treated with 65 mM KCl or 0 cal-
cium showing that depolarization causes a pro-
nounced decrease in Cx31.1 expression. mRNA
levelsarenormalized tomRNA levels inunstimu-
lated cells (bars represent mean ± SEM; n = 5).
(C) Western blots showing reduced expression
of FLAG-tagged rat CaV1.2 expressed in Neu-
ro2A cells by expression of two rat shRNAs
(RCaV1.2 sh6410 and RCaV1.2 sh6500; lanes 1
and 2, top panel) but not by a mouse shRNA
(MCaV1.2 sh6203) that differs by two base pairs
(lane 3, top panel). CaV1.2DTA is resistant to
RCaV1.2 sh6500 (lane 4), which targets the TA
domain of CaV1.2. Ds-Red, expressed from
the shRNA vector, was used as a loading control
(bottom panel).
(D) Mean luciferase activity (± SD) of rat neurons
transfected with the Cx31.1-luciferase-reporter
gene and either a scrambled control shRNA
(sh-scr), shRNA constructs targeting the mouse
CaV1.2 (MCaV1.2 sh-6203), or the rat CaV1.2
mRNAS (shRNA RCaV1.2 sh-6500, RCaV1.2
sh-6410; ** p < 0.001 versus scrambled (sh-
scr) or MCav1.2 sh-6203).
(E) CCAT* is resistant to knockdown by an
shRNA targeting CaV1.2 (CaV1.2 sh6500). West-
ern blot analysis of lysates from Neuro2A cells
expressing CCAT or an RNAi-resistant CCAT*
along with the RCaV1.2 sh-6500 shRNA vector
that targets rat CaV1.2 (upper gel). Ds-Red, ex-
pressed from the shRNA vector, was used as
a loading control (lower gel).
(F) Expression of RNAi-resistant CCAT*
reversed the effect of CaV1.2 sh6500 on
Cx31.1 expression (bar 3), but CCATDTA, which
lacks the C-terminal transactivation domain, does not (bar 4; means ± SD; n = 3; ** p < 0.001 versus sh-scr).
(G) CaV1.2-FLAG* is resistant to knockdown by RCav1.2 sh6500. Western blot analysis of lysates from Neuro2A cells expressing CaV1.2-FLAG or RNAi-
resistantCaV1.2-FLAG*,andRCaV1.2 sh6500orMCaV1.2sh-6203 (uppergel).Ds-Red, expressed from theshRNA vector, wasusedasa loading control
(lower).
(H)ExpressionofRNAi-resistantCaV1.2-Flag*partially reversed theeffect ofRCaV1.2sh6500on Cx31.1expression (bar 3),butCaV1.2-DTA*,which lacks
the C-terminal transactivation domain, did not (bar 4; means ± SD; n = 3). ** p < 0.0001 versus sh-scr.electrical activity of a cell. CCAT is generated from the
L-type channel, and its nuclear localization is negatively
regulated by the electrical activity of the cell; it is therefore
in a privileged position to integrate information about the
number of channels with information about the calcium
history of a cell.
Several laboratories have reported that LTCs are
cleaved at their C terminus, and the site of cleavage of
Cav1.1, the homologous LTC in skeletal muscle, was re-
cently identified (Hulme et al., 2005). The cleaved channel
carries more calcium, so channel cleavage could have
profound effects on the electrical properties of a neuron
by changing the properties of the LTC. The proteolytically602 Cell 127, 591–606, November 3, 2006 ª2006 Elsevier Inc.processed C-terminal domain is also thought to bind to
truncated channels, where it exerts an inhibitory effect
on channel function (Hulme et al., 2006). This hypothesis
does not preclude the idea that the C terminus of CaV1.2
also acts as a transcription factor. By analogy with the po-
tassium-channel binding protein KChip/DREAM, which is
also a calcium-sensitive transcriptional repressor, we pro-
pose that CCAT both regulates transcription and reduces
calcium influx through CaV1.2 (An et al., 2000; Carrion
et al., 1999). This hypothesis is appealing in light of the ob-
servation that CCAT is exported from the nucleus by ele-
vations in intracellular calcium, suggesting that under con-
ditions of tonically elevated calcium, CCAT would both
Figure 7. CCAT Regulates Neurite
Growth in Primary Neurons
(A and B) Representative low- and high-magni-
fication images of cerebellar granule cells
grown in vitro for 5 days transfected with a vec-
tor expressing GFP and either CCATDTA (A) or
CCAT (B).
(C) Histograms of mean neurite length for gran-
ule neurons expressing CCATDTA (top graph),
a vector with GFP alone (middle graph), or
CCAT (bottom graph).
(D) Average neurite length for cells expressing
CCATDTA, GFP alone, or CCAT (means ±
SEM, n = 200; ** p < 0.005 versus vector
control).
(E) Average number of primary dendrites for
granule neurons expressing CCATDTA, empty
vector, or CCAT.alter the transcription of specific genes and inhibit the ac-
tivity of CaV1.2. Thus CCAT may be an important part of
a negative-feedback pathway regulating both gene ex-
pression and calcium influx in the neurons.
In addition to CaV1.2, it has also been reported that
CaV1.3 (Hell et al., 1993), CaV2.1 (Kubodera et al., 2003),
and CaV2.2 (Westenbroek et al., 1992) are cleaved in neu-
rons. In the case of CaV2.1, the cleavage product is also
approximately 75 kDa and has been localized to the nu-
cleus of Purkinje neurons in the cerebellum (Kordasiewicz
et al., 2006). This suggests that C-terminal cleavage is
a general feature of CaV channels and that other members
of this family may also be transcriptional regulators. In our
studies, we did not find that the C-terminal domains of
CaV1.3 or CaV2.1 activated transcription in cortical neu-
rons, but it is possible that the C-terminal domains of other
channels may act in other types of neurons or may be tran-
scriptional repressors or regulators of chromatin struc-
ture. This would be consistent with our finding that in ad-
dition to activating transcription CCAT also represses the
transcription of many genes.
Despite more than a decade of experiments, the stimuli
and mechanisms that lead to cleavage of CaV1.2 remain
enigmatic. It has been reported that cleavage of CaV1.2is triggered by NMDA stimulation in hippocampal slices
(Hell et al., 1996), and CaV1.2 cleavage has also been re-
ported to occur in response to sex-hormone stimulation
of uterine muscle (Helguera et al., 2002). We did not ob-
serve any obvious increase in CCAT following stimulation
of neurons in culture with NMDA or potassium chloride;
however, it is possible that CaV1.2 cleavage only occurs
in the context of hippocampal slices. In cortical neurons,
cerebellar granule cells, cardiac myocytes, Neuro2A cells,
and PC12 cells exogenous CaV1.2 appears to be cleaved
constitutively to yield nuclear and cytoplasmic CCAT.
While the production of CCAT did not appear to be regu-
lated, its nuclear localization and its transcriptional effects
on the Cx31.1 gene were strongly regulated by changes in
cytoplasmic calcium. Therefore, we favor the idea that
CCAT is produced in proportion to the number of CaV1.2
channels in cells and that cytoplasmic calcium levels reg-
ulate its nuclear localization and transcriptional activity. In
addition to being regulated by calcium, nuclear CCAT
levels were also regulated in a cell-specific manner, and
its appearance in brain nuclear fractions increased sub-
stantially over the course of postnatal development. In
cultured neurons, CCAT levels were highest in GABAergic
inhibitory neurons, while in brain slices CCAT stainingCell 127, 591–606, November 3, 2006 ª2006 Elsevier Inc. 603
was particularly strong in the inferior colliculus, inferior
olive, and thalamus. These data suggest that CCAT may
play an important role in the development of neurons
and in regulation of neuronal properties in specific cell
types.
Our studies have identified many interesting genes reg-
ulated by CCAT, and these genes offer clues to under-
standing CCAT’s physiologic function. CCAT regulates
the expression of several gap-junction proteins, a gluta-
mate receptor, several potassium channels, a sodium-
calcium exchanger, and signaling proteins such as
RGS5, Formin, and Nitric Oxide Synthase. One of the
main targets of CCAT in the nucleus is the gap-junction
protein Cx31.1. Cx31.1 is expressed in the retina (Gulde-
nagel et al., 2000), in developing embryos (Davies et al.,
1996), and in GABAergic striatal-output neurons of the
thalamus (Venance et al., 2004). Our array and RT-PCR
studies suggest that Cx31.1 is also well expressed in neu-
roblastoma cells and in thalamic neurons. Transcription of
the Cx31.1 gene correlates well with the amount of endog-
enous CCAT in the nucleus and depolarization, which re-
duces the amount of nuclear CCAT and also decreases
the amount of Cx31.1 transcript, suggesting that these
two are correlated. Finally CCAT binds to the promoter
of Cx31.1, providing compelling evidence that CCAT is
a regulator of Cx31.1 expression in neurons. Connexins
play a key role in forming electrical connections between
developing neurons and form conduits for signaling mole-
cules that can regulate a developing tissue. The expres-
sion of Cx31.1 during development in response to
changes in CCAT could thus play an important role in reg-
ulating the electrical coupling of neurons and the overall
excitability of the brain.
We have found that CCAT expression in neurons in-
creases dendritic length. This effect is blocked by CCAT
lacking a transcriptional activation domain. There are
many possible mechanisms for this effect of CCAT on
neuronal morphology. The observation that CCAT upregu-
lates Cx31.1, formin, claudin 19, procolagen type XI, and
an a-catenin-like protein suggests that it might promote
the formation of adhesion complexes or junctional con-
tacts between neurons and the extracellular matrix. Alter-
natively, since CCAT increases the production of Netrin4
and of two chemokines that regulate axonal and dendritic
growth, it could lead to increases in neurite length via these
mechanisms (Adler and Rogers, 2005; Barallobre et al.,
2005). Finally, by downregulating a potassium channel
and a sodium-calcium exchanger, CCAT could increase
the excitability of neurons and thus regulate their morphol-
ogy indirectly. Understanding how CCAT modulates den-
dritic length might help uncover the mechanisms by which
L-type calcium channels regulate neuronal morphology.
We provide strong evidence that CaV1.2 encodes a tran-
scription factor that can regulate expression of a variety of
genes that are important for the function of neurons and
muscle cells. This finding reveals an entirely unsuspected
function for a well-characterized calcium channel that
plays an essential role in electrical tissues. This new func-604 Cell 127, 591–606, November 3, 2006 ª2006 Elsevier Inc.tion of CaV1.2 will be a rich area for future study in ion
channel physiology and neurobiology.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
HEK 293T cells and Neuro2A and PC12 cells were cultured in Dulbec-
co’s Minimal Essential Media (DMEM) containing 10% fetal bovine se-
rum (FBS; 15% for PC12s), penicillin, streptomycin (P/S), and L-gluta-
mine (LQ). Cortical neurons were dissociated from E17-19 Sprague
Dawley rats as described (Xia et al., 1996) and maintained for 6–14
days in culture in Basal Medium Eagle with 5% FBS, P/S, LQ, and
1% glucose or in Neurobasal medium containing B27 supplement (In-
vitrogen). Cardiac myocytes were cultured from P0–P1 rats using
a neonatal myocyte isolation kit (Cellutron Life Technology) and main-
tained in DMEM with 10% FBS, P/S, LQ, and 0.1 mM BRDU for 3–4
days. Cerebellar granule cells were cultured from P5 Sprague Dawley
rats and grown as described elsewhere (Dudek et al., 1997). For de-
scription of thalamic neuron cultures see Supplemental Experimental
Procedures.
HEK 293T (24 hr) cells, cortical and granule neurons (72 hr) were
transfected using a standard calcium-phosphate method at a concen-
tration of 2 mg of DNA/106 cells. Neuro2As (24 hr), cortical neurons (96
hr), cardiac myocytes (24 hr), and PC12s (24 hr) were transfected using
lipofectamine 2000 according to manufacturer’s instructions. For lucif-
erase reporter gene experiments see Supplemental Experimental
Procedures.
Plasmid Construction
See Supplemental Experimental Procedures.
Antibody Generation
Peptides of the following sequence DPGQDRAVVPEDES were synthe-
sized (Covance), coupled to KLH (Pierce), injected into rabbits, and af-
finity purified as previously described (Datta et al., 1997).
Subcellular Fractionation and Western Blotting
The brain was rapidly removed and homogenized in 320 mM sucrose
and 20 mM HEPES homogenization buffer, pH 7.2, containing 1 mM
EDTA, 1 mM dithiothreitol, Complete protease inhibitors (Roche Ap-
plied Science), and calpain inhibitors (A.G. Scientific). The homoge-
nate was centrifuged for 10 min at 1000 g to obtain the nuclear fraction.
The supernatant was then centrifuged for 30 min at 100,000 g at 4C to
obtain the cytoplasmic and membrane fractions. The nuclear pellet
was extracted using the Dignam method (Dignam et al., 1983). For
membrane bound channel visualization, proteins were extracted as
described previously (Haase et al., 2000). Western blotting was con-
ducted using standard protocols. Antibodies and dilutions are in-
cluded in Supplemental Experimental Procedures. Protein concentra-
tion was measured by the BCA method (Pierce).
Immunofluorescence
6 day-old cortical cultures cells were fixed in 4% paraformaldehyde/
2% sucrose, permeabilized, and blocked with 3% bovine serum albu-
min (BSA) in phosphate-buffered saline (PBS). Neurons were stained
with either rabbit anti-CCAT or rabbit anti-Cav1.2 II-III loop (each di-
luted 1:100) and anti-GAD65 followed by 1:500 dilutions of Alexa
594-conjugated anti-mouse and Alexa 488-conjugated anti-rabbit an-
tibodies (Molecular Probes). Nuclei were stained using Hoechst 33258
(Molecular Probes). Neuro2A cells expressing CCAT-ER fusions were
stained with mouse anti-myc tag (Upstate). P30 rat-brain sections
were a gift from Dr. Ben Barres. Sections were blocked and permeabi-
lized 30 min using 10% goat serum, 0.25% Triton X-100 in PBS. Pri-
mary and secondary antibody incubations were done as described
above. Slides were visualized by conventional epifluorescence micro-
copy using a cooled CCD camera (Hamamatsu) coupled to an inverted
Nikon Eclipse E2000-U microscope. Confocal images were obtained
using the Volocity grid confocal microscope (Improvision, Inc.).
Quantitative Image Analysis
Images were analyzed using OpenLab 4.0.4 software (Improvision,
Inc.). For measurements of nuclear and cytoplasmic fluorescence,
nuclear and whole-cell regions of interest (ROI) were generated by
density slicing the Hoechst and anti-CCAT images, respectively, and
cytoplasmic ROIs were obtained by subtraction. Fluorescence mea-
surements were analyzed using Igor Pro software (Wavemetrics).
Fluorescence Recovery after Photobleaching (FRAP)
FRAP experiments were conducted at 37C using a Zeiss Axiovert
200 M inverted microscope coupled to a Coolsnap cooled CCD cam-
era controlled by Slidebook software. Bleaching was achieved with a
100 ms long 488 nm laser pulse. Images were captured every 400 ms.
Luciferase Assays
Most luciferase assays were performed 24 hr after transfection using
the Dual-Glo luciferase assay kit from Promega. For shRNA experi-
ments, assays were performed 72 hr posttransfection. A Veritas 96-
well luminometer (Turner Biosystems) was used to measure light emis-
sion. CREB-Gal4, constitutively active PKA, and PFA-CMV constructs
were obtained as part of the PathDetect transreporting system from
Strategene. Data sets were analyzed using Igor Pro and Prism4 soft-
ware. Two-paired t tests were performed between relevant conditions.
Immunoprecipitation and Mass Spectrometry
HEK 293T cells were transfected with c503-Gal4 or c280-Gal4. Twenty-
four hours after transfection, immunoprecipitations were carried out
using the ProFound Coimmunoprecipitation Kit (Pierce) and mouse or
rabbit anti-Gal4 antibodies (Santa Cruz Biotechnology). SDS-PAGE
gels were silver stained using the SilverQuest system from Invitrogen.
Individual bands were analyzed by Stanford Mass Spectrometry facility
using LC-MS/MS as previously described (Shevchenko et al., 1996).
RNA Isolation and Oligonucleotide Microarrays
Neuro 2A cells were transfected using the CCAT-PA1, CCATDTA-PA1,
or PA1 control vectors. Twenty-four hours after transfection, cells were
trypsinized and resuspended in fresh media without phenol red, and
GFP-positive cells were sorted using FACS. RNA was isolated from
2 3 106 cells using an RNAeasy kit from Qiagen. RNA was hybridized
to Agilent whole-mouse oligomicroarrrays by MOgene, Inc. (St. Louis,
MO). Expression data was analyzed using GeneSpring GX 7.3 soft-
ware (Agilent).
RT-PCR
First-strand synthesis was conducted using the first-strand cDNA syn-
thesis kit from Invitrogen. Five-hundred nanograms of cDNA was used
as a template for RT-PCRs performed using an Mx3000P Real-Time
System (Stratagene), and the reactions were carried out using Quanti-
tec SYBR green PCR master mix (Qiagen). For a list of primers see
Supplemental Experimental Procedures.
Cycling parameters were 95C for 10 min, followed by 45 cycles of
95C for 30 s, 55C for 1 min, 72C for 30 s. Fluorescence intensities
were analyzed using the manufacturer’s software, and relative amounts
were obtained using the 2–DDCt method (Livak and Schmittgen, 2001).
ChIP
ChIP was carried out as described in the Upstate Biotechnology pro-
tocol. Briefly 107 cells were transfected with CCAT-GST or CCAT-
Gal4, or GST or Gal4 alone as controls. Proteins were crosslinked to
DNA with 1% paraformaldehyde for 10 min, and the nuclei were iso-
lated by centrifugation. The DNA was sheared by sonication to gener-
ate DNA fragments between 200 and 1000 bp. The C-terminal fusion
proteins were immunoprecipitated, washed, and uncrosslinked by
adding high salt and incubating at 65 overnight. DNA was recoveredby phenol/chloroform extraction and ethanol precipitation and used as
a template for PCR. For primer sequences see Supplemental Experi-
mental Procedures. Reaction products were visualized by agarose
gel electrophoresis.
Dendritic Arborization Assays
Cerebellar granules cells were imaged 24–48 hr posttransfection using
the ImageXpress 500A system (Molecular Devices). Dendrites were
analyzed employing ImageJ and NeuroJ programs.
Supplemental Data
Supplemental Data include four figures, four tables, experimental pro-
cedures and can be found with this article online at http://www.cell.
com/cgi/content/full/127/3/591/DC1/.
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